tradingkey.logo

Nutriband up after FDA grants meeting for firm's fentanyl patch

ReutersAug 8, 2025 2:12 PM

Shares of transdermal pharma products maker Nutriband NTRB.O rise 3.5% to $7.38

Nutriband says FDA grants meeting request for co's fentanyl patch

The meeting is scheduled for September 18 in which the regulator will provide feedback on co's marketing application for fentanyl patch

NTRB is developing Aversa, a proprietary technology that makes transdermal patches safer by preventing abuse and misuse of potent opioids like fentanyl

Including session moves, stock up 52.44% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI